Exceptional antitumor responses beyond immune checkpoint inhibition in non-small cell lung cancer patients: insights into optimal therapy sequencing.
作者信息
Charpidou Andriani, Vathiotis Ioannis, Gkiozos Ioannis, Syrigos Konstantinos
机构信息
Oncology Unit, 3rd Department of Medicine, "Sotiria" General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
J Thorac Dis. 2019 Mar;11(3):E25-E31. doi: 10.21037/jtd.2019.02.38.
Abstract
摘要
相似文献
1
Exceptional antitumor responses beyond immune checkpoint inhibition in non-small cell lung cancer patients: insights into optimal therapy sequencing.
J Thorac Dis. 2019 Mar;11(3):E25-E31. doi: 10.21037/jtd.2019.02.38.
2
Immune checkpoint inhibitors in advanced non-small cell lung cancer.
Cancer. 2018 Jan 15;124(2):248-261. doi: 10.1002/cncr.31105. Epub 2017 Dec 6.
3
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.
Pharmacotherapy. 2015 Oct;35(10):963-76. doi: 10.1002/phar.1643.
4
Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):153-164. doi: 10.1016/j.ijrobp.2017.05.029. Epub 2017 May 26.
5
A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.
Neoplasia. 2017 Jul;19(7):530-536. doi: 10.1016/j.neo.2017.02.004. Epub 2017 Jun 3.
6
Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC.
Cancer Treat Rev. 2018 Apr;65:65-77. doi: 10.1016/j.ctrv.2018.02.005. Epub 2018 Feb 22.
7
Immunotherapy in lung cancer.
Transl Lung Cancer Res. 2014 Feb;3(1):2-14. doi: 10.3978/j.issn.2218-6751.2013.10.13.
8
Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.
Expert Opin Biol Ther. 2016 Oct;16(10):1209-23. doi: 10.1080/14712598.2016.1214265. Epub 2016 Aug 5.
9
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer.
Drug Resist Updat. 2019 Sep;46:100644. doi: 10.1016/j.drup.2019.100644. Epub 2019 Sep 17.
10
Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies.
Chest. 2017 Apr;151(4):891-897. doi: 10.1016/j.chest.2016.10.007. Epub 2016 Oct 18.
引用本文的文献
1
Real-World Treatment Patterns and Outcomes Among Patients With Metastatic NSCLC Previously Treated With Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors.
JTO Clin Res Rep. 2022 Jan 1;3(2):100275. doi: 10.1016/j.jtocrr.2021.100275. eCollection 2022 Feb.
本文引用的文献
1
Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Lung Cancer. 2017 Oct;112:90-95. doi: 10.1016/j.lungcan.2017.07.034. Epub 2017 Aug 3.
2
Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer.
J Thorac Oncol. 2018 Jan;13(1):106-111. doi: 10.1016/j.jtho.2017.10.011. Epub 2017 Oct 31.
3
Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy.
J Intern Med. 2018 Feb;283(2):110-120. doi: 10.1111/joim.12708. Epub 2017 Nov 16.
4
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?
Crit Rev Oncol Hematol. 2017 Nov;119:30-39. doi: 10.1016/j.critrevonc.2017.09.007. Epub 2017 Sep 19.
5
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.
Mol Cancer Ther. 2017 Nov;16(11):2598-2608. doi: 10.1158/1535-7163.MCT-17-0386. Epub 2017 Aug 23.
6
Cancer Statistics, 2017.
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
7
-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors.
Onco Targets Ther. 2016 Dec 21;10:101-112. doi: 10.2147/OTT.S122974. eCollection 2017.
8
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
N Engl J Med. 2016 Nov 10;375(19):1823-1833. doi: 10.1056/NEJMoa1606774. Epub 2016 Oct 8.
9
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.
Oncologist. 2017 Jan;22(1):81-88. doi: 10.1634/theoncologist.2016-0189. Epub 2016 Aug 17.
10
Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives.
J Natl Cancer Inst. 2016 Feb 2;108(6):djv414. doi: 10.1093/jnci/djv414. Print 2016 Jun.
Zotero 插件